A New Era for U.S. Pharmaceutical Production: Onshore, Agile, and Powered by Certified Data
A quiet revolution is reshaping America’s pharmaceutical manufacturing capabilities—one that blends cutting-edge science, real-time data integrity, and strategic onshoring to strengthen the nation’s drug supply chain. On a recent episode of Around The Block, the podcast powered by Circular Protocol, leaders from Bright Path Laboratories outlined how the future of U.S. medicines is becoming decentralized,...









